Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
about
Case-specific potentiation of glioblastoma drugs by pterostilbeneDifferential pro-apoptotic effects of synthetic 4-thiazolidinone derivative Les-3288, doxorubicin and temozolomide in human glioma U251 cells.CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.In vitro screening for drug repositioning.Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypesEmerging targets for glioblastoma stem cell therapyScalable Production of Glioblastoma Tumor-initiating Cells in 3 Dimension Thermoreversible Hydrogels.Pitavastatin suppressed liver cancer cells in vitro and in vivoDisabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma.The effect of statins on cancer cells--review.In Vitro Effect of 8-Prenylnaringenin and Naringenin on Fibroblasts and Glioblastoma Cells-Cellular Accumulation and Cytotoxicity.Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis.Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta.In vitro screening of clinical drugs identifies sensitizers of oncolytic viral therapy in glioblastoma stem-like cells.In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells.Atorvastatin Promotes Cytotoxicity and Reduces Migration and Proliferation of Human A172 Glioma Cells.Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells.Statin and Bisphosphonate Induce Starvation in Fast-Growing Cancer Cell Lines.Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma MultiformeCorrection: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.Obstacles to Brain Tumor Therapy: Key ABC Transporters.Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells.Identification and preclinical evaluation of the small molecule, NSC745887, for treating glioblastomas via suppressing DcR3-associated signaling pathways.High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.
P2860
Q29048651-03BA57FD-72EA-45F4-9F0D-D778CFC6FD08Q32178363-7C4DE9DB-4F5B-46BB-9982-56507A43B27BQ34437996-D4147D32-E9F4-4796-BADB-79F6952D7ECAQ35531225-9223771D-2015-49BD-B501-54E82506A156Q35794896-526624EF-C107-44F3-81F8-37060F4A3A89Q36111611-F276FA3B-5BE4-4AD9-8ED5-DD358F514441Q36502009-E296A7F0-C59F-4C62-B37B-DF163C2492BFQ37195569-A73ADB8E-125C-405F-9648-3DACB6B0CF2DQ37229801-CD62CEF2-650E-437C-84B7-3E7E0A905E99Q37716459-CE346597-B4EF-4E0B-BE59-EE407487F28EQ38499265-55EC0066-11B0-4D54-A913-F7807DEFF49FQ38700364-EC9DB4C7-35C2-455E-A789-04DBB5E864B2Q38785665-79D5EA54-57BC-4EA9-9D8A-8FED20BBEB93Q38843924-EB3B9CCD-CAC0-4B98-9BFC-8AE96119A257Q38850871-132CFA5E-0EC5-4E57-8701-7244AF499F8AQ38968601-EA3F9C10-A9CD-4870-8B57-5FE079B0AB7CQ38970520-9CC47BE3-F5E2-4334-BC47-956F0502CC46Q39555400-E28D4BE2-06B4-4195-96B7-4D9822EADE9EQ41660477-F4E3B7F1-76BF-4473-80F8-1C18FA25BFAAQ41916031-9A5B5540-3846-405A-8F07-48BCAF5DB312Q42379504-A78D9C35-E140-4ABC-8C7B-4BA344924DE2Q42577813-F637E4B4-DA04-43BF-A529-2154D725EC47Q45801356-8152CE7A-676C-4F1C-A808-E58683A8E6ABQ47944360-CE2413A9-CB3A-4727-A541-6B08D38E04EAQ50290480-9D1D67FD-4760-44E6-BD21-B405EB07E6C1Q52649617-E86FB659-F112-4D04-B405-B3CD39F1A7FEQ52677063-D0AE602C-8C1D-4750-95DC-2D8D7D91EBC7
P2860
Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@ast
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en-gb
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@nl
type
label
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@ast
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en-gb
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@nl
prefLabel
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@ast
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en-gb
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@nl
P2093
P2860
P3181
P356
P1476
Novel anti-glioblastoma agents ...... llection of FDA approved drugs
@en
P2093
Ila Sri Bharati
Matt Gallagher
Milan Makale
Natsuko Nomura
Pengfei Jiang
Rajesh Mukthavaram
Rajesh Mukthavavam
Sandeep C Pingle
Santosh Kesari
Shireen Vali
P2860
P2888
P3181
P356
10.1186/1479-5876-12-13
P407
P577
2014-01-01T00:00:00Z
P5875
P6179
1049171734